Sveriges mest populära poddar

DTC Healthcare with 23andMe CEO Anne Wojcicki

26 min•24 april 2022

Genes aren’t always predictive, but understanding them better could dramatically improve our healthcare system. Motley Fool contributor Brian Orelli interviews Anne Wojcicki, the CEO of 23andMe, about her company and why it’s looking to tell you much more than the names of your long-lost relatives. They discuss: - Opportunities in direct-to-consumer healthcare - Creating more personalized medicine - The limits of genetic testing

Host: Brian Orelli Guest: Anne Wojcicki Producer: Ricky Mulvey Engineers: Dan Boyd, Brandon Gentry

Learn more about your ad choices. Visit megaphone.fm/adchoices

Fler avsnitt av Motley Fool Hidden Gems Investing

Big Banks Cash In, IBM Crashes Out

14 juli•24 min

2 Hidden Businesses to Watch as AI Keeps Heating Up

13 juli•20 min

Why Most AI Projects Will Fail — And How to Find the Companies That Won't

12 juli•27 min

Trump Accounts Are Live, But Are They the Best Choice?

11 juli•28 min

What History Teaches Us About Today’s Market

10 juli•41 min

Meta Has Been Busy

9 juli•28 min

Oil Pulls the Market Lower Again

8 juli•23 min

AI Expectations Hit a Fever Pitch

7 juli•23 min

Are Index Funds Making the Market “Irrational”?

6 juli•27 min

The Man Who Survived 47 Days on a Raft Has a Lesson for Every Investor

5 juli•24 min

Motley Fool Hidden Gems Investing med The Motley Fool finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.